Who is sponsoring NCT04156412?

NCT04156412 is sponsored by University Hospital, Rouen.

What drugs are being tested in NCT04156412?

Interventions in NCT04156412: Implant test procedure.

What condition does NCT04156412 study?

NCT04156412 studies Cardiac Resynchronisation Therapy.

Is NCT04156412 still recruiting?

NCT04156412 is currently completed. Last updated 6 February 2026.

Last reviewed 2026-02-06 · How we verify

NCT04156412: AXONE-Acute-2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AXONE-Acute II: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy

Completed NA Last updated 6 February 2026

What this trial tests

NA trial testing Implant test procedure in Cardiac Resynchronisation Therapy in 39 participants. Completed in 29 September 2020.

Timeline

2 January 2020

Primary endpoint
29 September 2020

29 September 2020

Quick facts

Lead sponsor	University Hospital, Rouen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	39
Start date	2 January 2020
Primary completion	29 September 2020
Estimated completion	29 September 2020
Sites	7 locations across France, Spain

Drugs / interventions tested

Implant test procedure

Conditions studied

Cardiac Resynchronisation Therapy — all drugs for Cardiac Resynchronisation Therapy →

Sponsor

University Hospital, Rouen

Who can join

18 and older, any sex, with Cardiac Resynchronisation Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pilot study to evaluate the performance of a lead below 2 French with specific distal shape to deliver efficient LV pacing

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Implant test procedure

Trials testing the same drug.

NCT03750058 — Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy · NA · completed

Other University Hospital, Rouen trials

Trials by the same sponsor.

NCT07441564 — Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Jux · NA · not yet recruiting
NCT07535944 — Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors · not yet recruiting
NCT07464184 — Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension · NA · not yet recruiting
NCT07359885 — Prediction of Postoperative Pulmonary Complications in Thoracic Surgery · not yet recruiting
NCT07247500 — Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04156412 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Rouen
Last refreshed: 6 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04156412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing